/ Press Release Details /

Point of Care Lipid Diagnostics Market Size Worth $296.8 Billion By 2025 | CAGR: 3.3%

The global PoC Lipid Diagnostics market is expected to grow at growth rate of 3.3% to reach USD 296.8 million by 2025.

Continuous increase in chronic diseases such as diabetes, cardiovascular disorders, and others will spur the market demand for point of care diagnostics lipid testing. According to the World Health Organization, cardiovascular disorder is one of the leading cause of death globally, In 201, approximately 17.7 million people died due to the cardiovascular disorders, representing around 30% of the global deaths. Such high prevalence and incidence rate of chronic diseases will stimulate the demand for POC testing, leading to driving the market growth. Furthermore, technological advancements, new product development, increasing investment by key companies coupled with the aging population act as a potential driver for the market growth. However, a high cost of these testing coupled with low awareness level in developing regions such as the Middle East and Africa will pull back the market growth to some extent over the forecast period.

To access highlight and table of content of this report, please click the link below:

http://www.analystviewmarketinsights.com/report-highlight-point-of-care-poc-lipid-diagnostics-market-151/

Key Takeaways:

Hyperlipidemia segment has captured the large share of the total market. Point of care testing for the analysis of lipid content is increasingly accepted among end-users.
Novel instruments such as Cholestech LDX System and CardioChek PA are commercially available which provides healthy platform for the growth of hyperlipidemia segment
Alere Cholestech LDx _Kits achieved significant revenue share among the other POC lipid instruments. This instrument is engineered to provide rapid, accurate and actionable results for point of care diagnostic lipid testing.
Testing technique by Alere Cholestech LDx instrument is certifies by the Cholesterol Reference Method Laboratory Method Network (CRMLN) programs and CDC’s Lipid Standardization Program (LSP)
Developed regions such as North America and Europe captured the largest share of the market due to the increasing demand of POC testing
Developing countries such as India and China exhibits immense growth opportunities in the point of care diagnostics market.
Increasing medical needs for target diseases and raising awareness initiatives for benefits of point of care testing in rural areas support the market demand

KEY BENEFITS OF THE REPORT:

In-depth analysis of the key factors are propelling the growth of the global market
Granular analysis of the current market scenario and the expected market grow
Detailed analysis of the geographic region that will witness the strongest growth
Highlight on the strategies that are being adopted by the key players in this market to stay competitive
Extensive analysis of the key players dominating the competitive landscape of this market

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

MARKET, BY APPLICATION